Risk-Reduction Therapy: The Challenge to Change
- 15 June 1996
- journal article
- other
- Published by Wolters Kluwer Health in Circulation
- Vol. 93 (12) , 2205-2211
- https://doi.org/10.1161/01.cir.93.12.2205
Abstract
No abstract availableThis publication has 17 references indexed in Scilit:
- Pravastatin limitation of atherosclerosis in the coronary arteries (PLAC I): Reduction in atherosclerosis progression and clinical eventsJournal of the American College of Cardiology, 1995
- Cholesterol Reduction in Cardiovascular Disease — Clinical Benefits and Possible MechanismsNew England Journal of Medicine, 1995
- The Human Costs of Tobacco UseNew England Journal of Medicine, 1994
- Triggers, acute risk factors and vulnerable plaques: The lexicon of a new frontierJournal of the American College of Cardiology, 1994
- Effect of enalapril on myocardial infarction and unstable angina in patients with low ejection fractionsThe Lancet, 1992
- The Effect of Warfarin on Mortality and Reinfarction after Myocardial InfarctionNew England Journal of Medicine, 1990
- Secondary prevention of vascular disease by prolonged antiplatelet treatmentBMJ, 1988
- Beta blockade during and after myocardial infarction: An overview of the randomized trialsProgress in Cardiovascular Diseases, 1985
- Determinants of dropout rate among hypertensive patients in an urban clinicJournal of Community Health, 1979
- The tardy growth of preventive cardiologyThe American Journal of Cardiology, 1972